
AZ and Cancer Research Horizons extend genomics partnership
Cancer Research Horizons and AstraZeneca have signed a five-year renewal of the Functional Genomics Centre, a facility dedicated to advancing drug discovery with genome-altering technologies such as CRISPR. The Functional Genomics Centre was established in 2019 to explore the function and interaction of genes and proteins… Read More















